2000
DOI: 10.1046/j.1432-1327.2000.01405.x
|View full text |Cite
|
Sign up to set email alerts
|

Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1

Abstract: The binding affinities of a number of amino-acid and peptide derivatives by the mammalian intestinal peptide transporter PepT1 were investigated, using the Xenopus laevis expression system. A series of blocked amino acids, namely N-acetyl-Phe (Ac-Phe), phe-amide (Phe-NH 2 ), N-acetyl-Phe-amide (Ac-Phe-NH 2 ) and the parent compound Phe, was compared for efficacy in inhibiting the uptake of the peptideIn an equivalent set of experiments, the blocked peptides Ac-Phe-Tyr, Phe-Tyr-NH 2 and Ac-Phe-Tyr-NH 2 were com… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

8
61
0

Year Published

2003
2003
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(70 citation statements)
references
References 16 publications
8
61
0
Order By: Relevance
“…The improvement of oral bioavailability of these antiviral prodrugs has been attributed to their carrier-mediatedtransport by oligopeptide transporters in the gastrointestinal tract (53)(54)(55)(56). A variety of promoieties, including amino acids, dipeptides, tripeptides, and their mimetics, have since been investigated for their suitability as substrates for carrier-mediated oligopeptide and amino acid transporters (57)(58)(59)(60)(61)(62). We have previously described the transport, enzymatic stability, and in vitro antiviral and cytotoxic activity characteristics of amino acid/dipeptide monoester prodrugs of anti-cancer drugs such as floxuridine and anti-virals such as 2-bromo-5,6-dichloro-1-(β-Dribofuranosyl)benzimidazole (BDCRB) and gemcitabine (14,20,21,45,46,63,64).…”
Section: Discussionmentioning
confidence: 99%
“…The improvement of oral bioavailability of these antiviral prodrugs has been attributed to their carrier-mediatedtransport by oligopeptide transporters in the gastrointestinal tract (53)(54)(55)(56). A variety of promoieties, including amino acids, dipeptides, tripeptides, and their mimetics, have since been investigated for their suitability as substrates for carrier-mediated oligopeptide and amino acid transporters (57)(58)(59)(60)(61)(62). We have previously described the transport, enzymatic stability, and in vitro antiviral and cytotoxic activity characteristics of amino acid/dipeptide monoester prodrugs of anti-cancer drugs such as floxuridine and anti-virals such as 2-bromo-5,6-dichloro-1-(β-Dribofuranosyl)benzimidazole (BDCRB) and gemcitabine (14,20,21,45,46,63,64).…”
Section: Discussionmentioning
confidence: 99%
“…For the epithelial transport via PEPT1, the structural requirements for substrate recognition have been clarified, in which essential structural features to possess are i) a free terminal carboxyl group and ii) at least one peptide bond (Tsuji and Tamao, 1996). The carbonyl group from the peptide bond has also been reported to be essential (Schoenmakers et al, 1999), since it interacts with His 57 from PEPT1 via an ionic interaction as the primary binding site for substrate (Meredith et al, 2000). The amino group has also been reported to be important for the binding to PEPT1 via ionic interactions (Meredith et al, 2000), suggesting that ionizing group(s) at the C-or N-termini in peptides are determinants for substrate recognition.…”
Section: Discussionmentioning
confidence: 99%
“…The carbonyl group from the peptide bond has also been reported to be essential (Schoenmakers et al, 1999), since it interacts with His 57 from PEPT1 via an ionic interaction as the primary binding site for substrate (Meredith et al, 2000). The amino group has also been reported to be important for the binding to PEPT1 via ionic interactions (Meredith et al, 2000), suggesting that ionizing group(s) at the C-or N-termini in peptides are determinants for substrate recognition. Although captopril and VY both fulfill these requirements for transport, one cannot fully explain their similar affinity toward PEPT1.…”
Section: Discussionmentioning
confidence: 99%
“…19) The absorption process of amino acids in the small intestine involves active transport with energy dissipation. 20,21) For example, Zhang et al 22) designed and synthesized diosgenin derivatives and investigated their antitumor activity. These experiments showed that most compounds had a defined activity.…”
mentioning
confidence: 99%